Pharma and food interests clash—insulin is costly, yet ultra-processed food remains unregulated.
Short excerpt from a YouTube conversation between an unidentified speaker and Dr. Ron Najafi. Main claims: insulin is becoming very expensive in the U.S. despite being older and cheaper in Canada/Europe; pharmaceutical incentives should change for long-established drugs; the food industry heavily markets/produces sugar-laden, ultra-processed foods to children and needs stronger regulation. The excerpt expresses a critical stance toward current pharma pricing and food-industry practices.
Chapters
More from Dr.
Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health
Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It
Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.
The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet
Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome
Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose
Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance
Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet